Sarepta Therapeutics, Inc. (SRPT) Shareholders’ equity 2016–2025
Sarepta Therapeutics, Inc. (SRPT) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.1BFY2025 · since FY2016: $336.7M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | -25.3% |
| FY2024 | $1.5B | +77.8% |
| FY2023 | $859.3M | +123.2% |
| FY2022 | $384.9M | -58.5% |
| FY2021 | $928.0M | +21.8% |
| FY2020 | $761.8M | -6.9% |
| FY2019 | $818.2M | -20.7% |
| FY2018 | $1.0B | +30.8% |
| FY2017 | $789.2M | +134.4% |
| FY2016 | $336.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice